Literature DB >> 31989811

Characterization of Protein Aggregation Using Hydrogel-Encapsulated nIR Fluorescent Nanoparticle Sensors.

Daniel P Salem1, Xun Gong1, Heejin Lee2, Alicia Zeng2, Gang Xue2, Jeff Schacherl2, Scott Gibson2, Michael S Strano1.   

Abstract

The monitoring of biopharmaceutical critical quality attributes in-process, at both the process development and manufacturing stages, is necessary for the implementation of process analytical technology and quality-by-design principles. Among these attributes, it is important to monitor and control protein aggregation during the manufacturing of biological therapeutics to prevent adverse immunogenic responses and minimize negative impacts on drug deliverability. In this work, we explore hydrogel-encapsulated, label-free fluorescent nanosensors for the characterization of protein aggregation. A mathematical model is used to describe the diffusion and binding of a series of stressed pharmaceutical samples to such sensors, describing their dynamic response. We use mathematical modeling to map the influence of hydrogel properties on the separation performance, given the composition of UV-stressed IgG1 samples. Using this modified model, the compositions of light-stressed IgG1 samples were fit to experimental data and correlated with size-exclusion chromatography data. The results demonstrate the ability to detect the presence of high-molecular-weight protein species at a concentration as low as 1%. This work represents a significant step toward the development and deployment of rapid process analytical technologies for biopharmaceutical characterization.

Entities:  

Keywords:  SWCNT; biopharmaceutical aggregation; biopharmaceutical characterization; biosensor; nanosensor; single-walled carbon nanotube

Mesh:

Substances:

Year:  2020        PMID: 31989811     DOI: 10.1021/acssensors.9b01586

Source DB:  PubMed          Journal:  ACS Sens        ISSN: 2379-3694            Impact factor:   7.711


  2 in total

1.  Optimizing the Preparation Procedure of Recombinant PSCA, as a Practical Biomarker in Prostate Cancer.

Authors:  Mahboube Shahrabi Farahani; Neda Saraygord-Afshari; Mohammad M Farajollahi
Journal:  Iran J Biotechnol       Date:  2021-04-01       Impact factor: 1.671

Review 2.  Developments and opportunities in continuous biopharmaceutical manufacturing.

Authors:  Ohnmar Khanal; Abraham M Lenhoff
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.